Omaxe accepts resignation of Neeraj Arora as Vice President – PMO

0 min read | Published on 11 Sept 2026, 12:19 PM |Updated on 11 Sept 2026, 12:19 PM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Key Highlights

Neeraj Arora resigns as Vice President – PMO at Omaxe
The resignation is effective September 10, 2026
Cited reason for departure is personal reasons
Disclosure made under Regulation 30 of SEBI LODR

*this image is generated using AI for illustrative purposes only.

Omaxe has accepted the resignation of Neeraj Arora from his position as Vice President – PMO. The exit is effective September 10, 2026, due to personal reasons.

The company disclosed the change in senior management personnel under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued on September 11, 2026.

Resignation Details

The filing confirms that Mr. Neeraj Arora stepped down from the Senior Management Personnel role. The company cited personal reasons for the cessation of employment.

Particulars	Details
Reason for change	Resignation
Date of cessation	September 10, 2026

D B R Srikanta, Company Secretary and Compliance Officer, signed the disclosure. The full intimation is available on the company’s website and the stock exchanges.

Historical Stock Returns for Omaxe

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.02%	-3.84%	+44.17%	+63.46%	+40.40%	0.0%

Who will be appointed as the new Vice President – PMO, and what is their professional background?

How might this leadership change in the PMO impact Omaxe's ongoing project delivery timelines and operational efficiency?

Are there any other senior management exits or hires planned in the near future that could signal broader organizational restructuring?

Omaxe

View Company Insights

View All News

Tribunal rejects appeal against SEBI order on Omaxe dated July 30, 2024

0 min read | Published on 02 Sept 2026, 07:18 PM |Updated on 02 Sept 2026, 07:18 PM

Reviewed by

Riya DScanX News Team

Add as a preferred
source on Google

Key Highlights

A tribunal rejected an appeal filed against a SEBI order dated July 30, 2024, involving Omaxe
The dismissal of the appeal means the original SEBI order remains in force
The ruling upholds the regulatory directive issued by the Securities and Exchange Board of India

*this image is generated using AI for illustrative purposes only.

Omaxe has been at the centre of a regulatory development after a tribunal rejected an appeal filed against a SEBI order dated July 30, 2024.

Tribunal ruling upholds SEBI's directive

The tribunal dismissed the appeal that had challenged the Securities and Exchange Board of India's order issued on July 30, 2024. With the rejection, the original SEBI order against Omaxe stands in force.

Detail	Information
Regulatory body	Securities and Exchange Board of India (SEBI)
SEBI order date	July 30, 2024
Development	Tribunal rejects appeal against the order
Outcome	Original SEBI order upheld

Regulatory context

The tribunal's decision to reject the appeal means that the directives contained in SEBI's July 30, 2024 order remain operative for Omaxe. The appeal had sought to challenge the findings or directions set out in that regulatory order, but the tribunal ruled against the appellant.

Historical Stock Returns for Omaxe

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.02%	-3.84%	+44.17%	+63.46%	+40.40%	0.0%

What specific compliance actions must Omaxe undertake to adhere to the upheld SEBI directives, and what is the expected timeline for implementation?

How might this regulatory setback impact Omaxe's stock price volatility and investor confidence in the near term?

Are there any potential financial penalties or restrictions on capital raising activities embedded in the SEBI order that could affect Omaxe's liquidity?

Omaxe

View Company Insights

View All News